Edition:
United Kingdom

NantKwest Inc (NK.OQ)

NK.OQ on NASDAQ Stock Exchange Global Select Market

1.25USD
20 Aug 2019
Change (% chg)

$-0.01 (-0.79%)
Prev Close
$1.26
Open
$1.26
Day's High
$1.26
Day's Low
$1.25
Volume
794
Avg. Vol
93,130
52-wk High
$4.23
52-wk Low
$0.93

About

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company is focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. Its immuno-oncology NK platform has multiple modes to induce cell death against the tumor or... (more)

Overall

Beta: --
Market Cap(Mil.): $405.94
Shares Outstanding(Mil.): 79.44
Dividend: --
Yield (%): --

Financials

  NK.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -1.27 -- --
ROI: -34.84 8.94 14.48
ROE: -35.88 10.07 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates